All chronic conditions such as cardiovascular disease and cancer have a strong and persistent
link with chronic inflammation. Inflammation promotes the production of free radicals, which is
a contributing factor to the onset of cancer.1,2
Although inflammation is an essential response to injury or infection, chronic inflammation is
harmful and causes tissue damage. Cancer and inflammation come together from both sides;
inflammation causes and promotes cancer, and cancer (“Cancer Energy”) creates inflammation.
In fact, cancer cells play an active part in stimulating bone marrow-derived cells (BMDCs) to
create a microenvironment—the “pre-metastatic niche”—that is favorable for growth and
metastasis. One of the primary ways they are able to do this is by upregulating inflammatory
pathways. The ability of metastatic cancer cells to stimulate production of interleukin-6 (IL-6),
and tumor necrosis factor-alpha (TNFa) is central to this process